Table 3. Microbiological analyses at the time of extubation between patients with extubation success and failure.
| Parameters | Extubation success (n = 82) | Extubation failure (n = 43) | P |
|---|---|---|---|
| Sputum (BALF) culture | |||
| Bacteria | |||
| Acinetobacter baumannii (%) | 50 (61.0) | 25 (64.1) | 0.741 |
| Pseudomonas aeruginosa (%) | 16 (19.5) | 5 (12.8) | 0.364 |
| Klebsiella pneumoniae (%) | 6 (7.3) | 4 (10.3) | 0.725 |
| Burkholderia cepacia (%) | 4 (4.9) | 2 (5.1) | 1.000 |
| Stenotrophomonas maltophilia (%) | 7 (8.5) | 3 (7.7) | 1.000 |
| Enterobacter cloacae (%) | 5 (6.1) | 1 (2.6) | 0.663 |
| Serratia marcescens (%) | 4 (4.9) | 0 (0) | 0.304 |
| Escherichia coli (%) | 3 (3.7) | 1 (2.6) | 1.000 |
| Haemophilus influenzae (%) | 0 (0) | 1 (2.6) | 0.322 |
| Bacillus mirabilis (%) | 2 (2.4) | 0 (0) | 1.000 |
| Staphylococcus aureus (%) | 3 (3.7) | 2 (5.1) | 0.657 |
| Fungi | |||
| Candida albicans (%) | 21 (33.9) | 11 (31.4) | 0.806 |
| Candida tropicalis (%) | 8 (12.9) | 1 (2.9) | 0.150 |
| Candida glabrata (%) | 5 (8.1) | 0 (0) | 0.156 |
| Candida krusei (%) | 1 (1.6) | 1 (2.9) | 1.000 |
| Candida parapsilosis (%) | 0 (0) | 1 (2.9) | 0.361 |
| Aspergillus fumigatus (%) | 2 (2.4) | 2 (5.0) | 0.597 |
| Blood culture | |||
| Bacteria | |||
| Acinetobacter baumannii (%) | 9 (13.4) | 5 (13.5) | 1.000 |
| Escherichia coli (%) | 0 (0) | 1 (2.7) | 0.356 |
| Enterococcus faecium (%) | 0 (0) | 1 (2.7) | 0.356 |
| Pseudomonas aeruginosa (%) | 1 (1.5) | 0 (0) | 1.000 |
| Urine culture | |||
| Bacteria | |||
| Escherichia coli (%) | 1 (3.4) | 0 (0) | 1.000 |
| Klebsiella pneumoniae (%) | 2 (6.9) | 0 (0) | 1.000 |
| Acinetobacter baumannii (%) | 2 (6.9) | 0 (0) | 1.000 |
| Fungi | |||
| Candida tropicalis (%) | 1 (3.6) | 0 (0) | 1.000 |
| Candida glabrata (%) | 2 (7.1) | 1 (10.0) | 1.000 |
| Candida albicans (%) | 3 (10.7) | 3 (30.0) | 0.310 |
| Serum viral IgM | |||
| Herpes Simplex virus (%) | 9 (15.5) | 5 (17.2) | 1.000 |
| Rubella virus (%) | 1 (1.7) | 0 (0) | 1.000 |
| Cytomegalovirus (%) | 0 (0) | 1 (3.4) | 0.330 |
| Epstein–Barr virus (%) | 4 (9.1) | 2 (11.1) | 1.000 |
Abbreviation: BALF, bronchoalveolar lavage fluid.